Switch to:
More From Other Websites
Alexion gets EU approval for drug acquired in Synageva deal Sep 01 2015
Columbia Wanger Sells 22 Stakes in Second Quarter Aug 17 2015
Bluebird, Pacira Pharmaceuticals Excite Life Science Investors Aug 12 2015
MDGN: Efficacy of Target EPO Now Through 13 Months Aug 11 2015
Alexion Facing Big Costs, Guidance Disappoints Jul 30 2015
Ultragenyx Downgraded At Morgan Stanley, Valuation 'Stretched' And Pipeline Faces Execution Risk Jul 27 2015
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns Jul 10 2015
ALEXION PHARMACEUTICALS, INC. Financials Jun 26 2015
SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Jun 23 2015
The Only Way to Play Biotech Buyouts Jun 09 2015
Why These 4 Biotech Stocks Could Be the Next Buyout Targets May 07 2015
Rich Synageva M&A premium epitomizes appetite for orphan drugs May 06 2015
Alexion Pharma to pay $8.4 billion for Synageva BioPharma May 06 2015
Is Alexion Grossly Overpaying for Synageva? May 06 2015
Alexion Pharma to buy Synageva BioPharma for $8.4 bln May 06 2015
Synageva BioPharma reports 1Q loss Apr 29 2015
Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY)... Mar 05 2015
Synageva BioPharma reports 4Q loss Feb 26 2015
New Year, New Biotech Stock Offerings -- Lots of 'Em Jan 05 2015
Biotech Bull Markets and Billion-Dollar Valuations Dec 23 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK